
🫀Cardiology resident @TecSaludMX @TecCardiology Internal medicine doctor 🏥 #eudaimonia 🌾🪐
México, Monterrey
Joined May 2017
- Tweets1.8K
- Following469
- Followers178
- Likes5K
Pinned Tweet
Replying to @eldanylira
Puede que te des cuenta, que el camino es la meta, tu felicidad es la meta. Plenitud de ser y vivir. #eudaimonia
6
Daniel Lira-Lozano retweeted
🫀 El TCT 2026 nos ha dejado novedades interesantes en cardiología intervencionista: ICP, imagen intracoronaria, valvular y cierre de orejuela.
➡️Repasamos los estudios que merece la pena conocer y qué implicaciones pueden tener en nuestra práctica.
Dentro hilo 👇
Daniel Lira-Lozano retweeted
Ten major RCTs involving >16,000 patients have evaluated imaging-guided versus angiography-guided PCI over the past decade.
Most demonstrated clinical benefit, although some reported neutral outcomes, highlighting the importance of patient selection, lesion complexity, and procedural optimization.
Clinical benefit likely depends on a comprehensive imaging-guided strategy, including procedural planning, real-time decision-making, post-stenting assessment, and correction of suboptimal results. #TCT2026
Daniel Lira-Lozano retweeted
Vascular aging as a driver of organ dysfunction and systemic aging
nature.com/articles/s44161-0…
Daniel Lira-Lozano retweeted
Intensive vs More Intensive Lipid-Lowering Therapy and Plaque Regression in Statin-Naive Patients
More intensive lipid-lowering therapy was associated with significantly greater regression of total and noncalcified coronary plaque burden compared with intensive therapy. The extent of plaque regression was related to achieved LDL-C levels, supporting the potential for partial reversal of coronary atherosclerosis with intensive lipid reduction.
jamanetwork.com/journals/jam…
Daniel Lira-Lozano retweeted
#Statin treatment in asymptomatic, intermediate-risk individuals was linked with plaque passivation and a shift toward higher density calcium within coronary plaques, new #JACCIMG research shows. bit.ly/3Uqcoi8
Daniel Lira-Lozano retweeted
🫀 Can coronary atherosclerosis actually regress?
Our new randomized FLOWPROMOTE trial analysis, published TODAY in JAMA Cardiology, shows remarkable coronary plaque regression with intensive LDL-C lowering!
Atherosclerosis is not necessarily a one-way process.
📄 JAMA Cardiology:
doi.org/10.1001/jamacardio.2…
#Atherosclerosis #LDL #Cardiology #CCTA
Daniel Lira-Lozano retweeted
Updated intro2echo.com with sections on structural heart echo.
Walks through the steps for TAVR, mTEER, and tTEER. This includes 3D models as well as simulated 2D ultrasound images.
Would appreciate feedback and suggestions for improvement!
intro2echo.com/#mteer
Daniel Lira-Lozano retweeted
On VA-ECMO, the pump delivers flow, but it can't provide tone or contractility. Here's how to pick the medication for vasoplegia, cardiogenic shock, and weaning. 🎩 tip to the authors, including @pwierusz.
eddyjoemd.com/foamed
Daniel Lira-Lozano retweeted
Intracoronary imaging to assess atherosclerosis and to guide percutaneous coronary intervention. Read this State-of-the-Art review just published in #EHJ
academic.oup.com/eurheartj/a…
@escardio @ESC_Journals #OCT #imaging
Daniel Lira-Lozano retweeted
Drug-Coated Balloons vs Drug-Eluting Stents: What Does the Evidence Show?
Our new meta-analysis of 10 RCTs (7,832 patients) led by @CorballisTash
@TheLancet @eClinicalMed
No difference in cardiovascular death or MI. But revasc may be higher.
thelancet.com/journals/eclin…
@NNUH
Daniel Lira-Lozano retweeted
Meta-analyses of intravascular imaging guidance of PCI show markedly improved outcomes, but only if you use this tool properly — pre-, intra- and post-PCI and with appropriate targets. How do you do it? Our new state-of-the-art review in EHJ takes you through it step by step.
Daniel Lira-Lozano retweeted
🚨 Temporary MCS in Cardiogenic Shock: What’s New in the 2026 ESC Consensus?
🔹 Phenotype before device: SCAI + SHARC + hemodynamics
🔹 Impella: Survival benefit in selected STEMI-CS (DanGer Shock), but more complications
🔹 VA-ECMO: No benefit with routine use in AMI-CS (ECLS-SHOCK)
🔹 Biventricular support: Promising physiology, limited randomized evidence
🔹 Define the exit strategy BEFORE initiating support
💡 More flow ≠ better survival.
The future of MCS lies in selecting the right patient, device, and timing—not simply escalating support.
📖 European Heart Journal, 2026
doi.org/10.1093/eurheartj/eh…
#CardiogenicShock #Impella #ECMO #HeartFailure
🤖 Made with AI
Daniel Lira-Lozano retweeted
6,000 years of world history on a single timeline. Zoom in. You could spend 30 minutes exploring this.
Daniel Lira-Lozano retweeted
Corelab annotations are a lot of work. Frame after frame, contour after contour, and the software we had made it hard.
So I built our own with @claudeai.
It’s called Coronaut. It was made entirely with Claude Code, to solve a problem we lived with every day. It takes an IVUS pullback and segments the lumen, EEM and stent struts automatically. I think it does a much better job than the software we had available. It also does 3D reconstructions and calculates FFR from the lumen.
Was it fast or easy? No. It’s been more than a year in the making. But it allowed us to overcome a barrier that would otherwise have blocked us forever. I know how to code, but how long would it take me to do this by myself? Years?
When I say AI will revolutionize medicine, this is what I mean. This is where doctors and chips meet, and I think it’s beautiful.
Is it perfect? No. It is not finished or validated yet, and it is for research purposes only at this time. But we are working on it constantly, and it’s coming along.
#CardiologyX #IVUS #AI
Daniel Lira-Lozano retweeted
Cardiopulmonary Bypass, ECMO, Impella, VAD: different machines, same vasoplegia. I tell families that their loved ones are having an "allergic reaction of sorts" to the artificial surfaces. 🎩 tip to the authors.
eddyjoemd.com/foamed
Daniel Lira-Lozano retweeted
The Athletes #ECG
State of the art review
doi.org/10.1016/j.jacadv.202…
Daniel Lira-Lozano retweeted
I created LearnCoronary (learncoronary.com), an interactive tool designed to help general cardiology fellows and other early-career learners better understand coronary angiography and the spatial relationships between different angiographic views.
#cardiotwitter @OpenAI
Daniel Lira-Lozano retweeted
Helpful decision aid to choose between PCI and CABG for patients presenting with LM stenosis.
Daniel Lira-Lozano retweeted
Now publ in EHJ: In 3 RCTs (n=704), 2-3-mo Rx w/DOACs (low dose in 2 trials) ↓ device-related thrombosis (DRT) and major bleeding c/w DAPT, with NS Δ in death and stroke/SE. DRT has been associated with thromboembolic events, and the RR of 0.61 for stroke/SE favors DOAC use.






































